Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy-Reference-Cited by-同舟云学术

Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

Published:2021-10 Issue: Volume:192 Page:114666
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Vigón Lorena,Martínez-Román Paula,Rodríguez-Mora Sara,Torres Montserrat,Puertas María C.,Mateos Elena,Salgado María,Navarro Antonio,Sánchez-Conde Matilde,Ambrosioni Juan,Cervero Miguel,Wyen Christoph,Hoffmann Christian,Miró José M,Alcamí José,Podzamczer Daniel,García-Gutiérrez Valentín,Martínez-Picado Javier,Briz Verónica,Rosa López-Huertas María,Planelles Vicente,Coiras Mayte,Corona Magdalena,del Mar Díaz-Goizueta María,Knops Elena,Luna de Abia Alejandro,Martín-Carbonero Luz,Ryan Pablo,Spivak Adam

Funder

National Institutes of Health

Gobierno de España Ministerio de Ciencia e Innovación

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference75 articles.

1. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;Finzi;Science,1997

2. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia;Wong;Science,1997

3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy;Chun;Proc. Natl. Acad. Sci. U S A,1997

4. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy;Rong;PLoS Comput. Biol.,2009

5. Re-emergence of HIV after stopping therapy;Chun;Nature,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV;Biochemical Pharmacology;2024-11

2. Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a “shock and kill” strategy for ART-free virological control: a phase II single-arm study;Signal Transduction and Targeted Therapy;2024-09-09

3. Targeting Viral Transcription for HIV Cure Strategies;Microorganisms;2024-04-08

4. A novel high-throughput microwell outgrowth assay for HIV-infected cells;Journal of Virology;2024-03-19

5. The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease;Frontiers in Immunology;2023-10-12